Recent Patents on Anti-Infective Drug Discovery
Title:Patent Selections
Volume: 12 Issue: 1
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Patent Selections, Recent Patents on Anti-Infective Drug Discovery 2017; 12 (1) . https://dx.doi.org/10.2174/1574891X1201171002151359
DOI https://dx.doi.org/10.2174/1574891X1201171002151359 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
11
Related Articles
-
Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Brutons Tyrosine Kinase as a New Therapeutic Target
Anti-Cancer Agents in Medicinal Chemistry Oesophagogastric Disconnection: Who, How and When? A Review Article
Current Pediatric Reviews Namitecan: a Hydrophilic Camptothecin with a Promising Preclinical Profile
Current Medicinal Chemistry Molecular Therapeutics of HBV
Current Gene Therapy Long Non-coding RNA MALAT1 Inhibits Neuron Apoptosis and Neuroinflammation While Stimulates Neurite Outgrowth and Its Correlation With MiR-125b Mediates PTGS2, CDK5 and FOXQ1 in Alzheimer's Disease
Current Alzheimer Research 30 Years Lost in Anesthesia Theory
Cardiovascular & Hematological Agents in Medicinal Chemistry Modulatory Factors Responsible for Neoangiogenesis in Young Patients with Long-Standing Diabetes Mellitus Type 1
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Lessons From HIV-1 Gene Therapy in Humanized Mice: Is Targeting Viral Entry the Road to Success?
Current Gene Therapy Identification of Target Antigens of Antiendothelial Cell Antibodies Against Human Brain Microvascular Endothelial Cells in Healthy Subjects
Current Neurovascular Research MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance
Current Medicinal Chemistry Tirzepatide: A New Generation Therapeutic for Diabetes Type 2
Endocrine, Metabolic & Immune Disorders - Drug Targets Von Willebrand Factor and Thrombosis: Risk Factor, Actor and Pharmacological Target
Current Vascular Pharmacology Comparison of Enzyme Kinetic Parameters Obtained In Vitro for Reactions Mediated by Human CYP2C Enzymes Including Major CYP2C9 Variants
Current Drug Metabolism IL-37 As a Potential Biotherapeutics of Inflammatory Diseases
Current Drug Targets Targeting Chemokine (C-X-C motif) Receptor 3 in Thyroid Autoimmunity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Nanoparticles vs Cancer: A Multifuncional Tool
Current Topics in Medicinal Chemistry The Role of NO-cGMP Signaling Pathway in Pancreatic Beta-cell Function
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Thyroid Ultrasound and Other Imaging Procedures in the Pediatric Age
Current Pediatric Reviews Sex Differences in Biomarkers for Predicting Cardiovascular and Coronary Events
Current Vascular Pharmacology